Paracetamol IN HUMAN BODY ACTION ON & BY LIVER.

Paracetamol is considered one of the safest drugs in clinical practice.

Yet, it remains one of the leading causes of acute liver failure worldwide.

This paradox is not about the drug itself — it’s about its metabolism.

After administration, paracetamol is primarily metabolized in the liver through two Phase II conjugation pathways:
• Glucuronidation (~60%)
• Sulfation (~30%)

These pathways produce non-toxic, water-soluble metabolites that are safely excreted.

However, a small fraction (<10%) undergoes Phase I metabolism via cytochrome P450 enzymes, predominantly CYP2E1, forming a highly reactive intermediate:
→ N-acetyl-p-benzoquinone imine (NAPQI)

Under normal conditions, NAPQI is rapidly detoxified by conjugation with glutathione (GSH), preventing cellular injury.

The situation changes completely in overdose or high-risk conditions (chronic alcohol use, enzyme induction, malnutrition):

• Hepatic glutathione stores become depleted
• Detoxification capacity is overwhelmed
• NAPQI accumulates and binds covalently to cellular proteins

This initiates:
• Oxidative stress
• Mitochondrial dysfunction
• Hepatocellular necrosis

Clinically, this progresses from asymptomatic elevation of liver enzymes to fulminant hepatic failure.

The therapeutic intervention is precise and time-dependent.

N-acetylcysteine (NAC) acts by:
• Replenishing intracellular glutathione
• Enhancing non-toxic metabolism
• Directly scavenging reactive oxygen species

When administered early, NAC can significantly reduce morbidity and mortality.

This entire pathway reinforces a fundamental principle of pharmacology:

The same molecule can be therapeutic or toxic — depending entirely on dose, metabolism, and patient-specific factors.

Understanding these mechanisms is what transforms pharmacology from memorization… into clinical reasoning.

Exploring drug action beyond textbooks.

Comments

Curated Compendium of Drug Discovery

Drug discovery is a multidisciplinary process that integrates biology, chemistry, pharmacology , and cutting-edge technologies to identify and develop new therapeutic agents. From target identification to lead optimization and clinical evaluation, each stage requires precision, innovation, and collaboration. A curated list of drug discovery resources provides researchers, students, and professionals with a structured pathway to explore advancements, tools, and strategies that shape modern therapeutics. This compilation serves as a gateway to understanding the evolution of drug discovery, recent breakthroughs, and future directions, fostering knowledge-sharing and accelerating translational research. Databases and Chemical Libraries General Compound Libraries DrugBank - Comprehensive data on approved and investigational drugs. ZINC - Free compounds for screening. ChemSpider - Chemical structures and data. DrugSpaceX - Chemical and biological spaces. Mcule ...

Understanding NMR Spectroscopy and Chemical Shift Ranges for Functional Groups

Nuclear Magnetic Resonance ( NMR ) spectroscopy is one of the most powerful analytical tools in pharmaceutical chemistry. It helps chemists determine the structure, purity, and chemical environment of molecules by analyzing the behavior of nuclei (commonly ¹H or ¹³C ) when exposed to a strong magnetic field. In proton NMR ( ¹H-NMR ), the chemical shift (δ, in ppm) provides information about the type of hydrogen atoms present in a compound and their surrounding electronic environment. Depending on nearby atoms and functional groups, signals appear in specific regions of the spectrum — often referred to as upfield (shielded, lower δ values) or downfield (deshielded, higher δ values). The image above summarizes the characteristic δ ranges for different functional groups in ¹H-NMR. Let us break it down systematically: 1. Downfield Region (δ 12 – 6 ppm) Hydrogens in this region are strongly deshielded due to electronegative atoms or π-bond systems. Carboxylic Acids (–COOH) : δ 1...

Pushing the boundaries of computational drug discovery at Isomorphic Labs

The Isomorphic Labs Drug Design Engine (IsoDDE) has unlocked a new frontier in in-silico drug design, representing a significant evolution beyond AlphaFold 3. What IsoDDE delivers: 🔹 Massive accuracy leap on unconstrained structure prediction The engine more than doubles AlphaFold 3's accuracy on extremely challenging protein-ligand prediction tasks — including systems far outside the training distribution. 🔹 Best-in-class binding affinity prediction IsoDDE predicts how strongly small molecules bind to targets with accuracy that exceeds gold-standard physics-based methods, at a fraction of the computational cost and time. 🔹 Blind identification of novel binding pockets Even without existing structural data, the engine reveals previously unseen binding sites — just from an amino acid sequence — enabling drug designers to explore entirely new chemical action spaces. 🔹 Expanded support for complex biologics Beyond small molecules, the engine boosts prediction fidelity for...

NEOPHARMA NUTSHELL COMMUNITY

Search This Blog